| Particulars |
|
|
|
| Company Name
| Bafna Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
23.66 |
B.V. (₹) |
38.60 |
| Sales(₹ Cr.) |
145.86 |
NP (₹ Cr.) |
6.37 |
| NP Var% |
-12.00 |
Div% |
0.00 |
| CPS(₹) |
4.80 |
EPS (₹) |
2.70 |
| Traded Value(₹ Lakhs) |
1.19 |
52 Week High |
205.00 |
| 52 Week Low |
68.00 |
Price BSE |
150.00 |
| Price NSE |
150.00 |
Market Capital (₹ Cr.) |
354.02 |
| P/C Ratio |
31.50 |
P/E Ratio |
55.70 |
| Price Vs.BV |
3.89 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
35.47 |
| NP(₹ Cr.) |
3.12 |
NP Var % |
19.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
143.45 |
| OPM |
5.07 |
NP |
0.75 |
| NP Var% |
1306.38 |
EPS |
4.47 |
| PE |
33.48 |
|
|